MassDevice.com +5 | The top 5 medtech stories for January 12, 2017

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Zimmer Biomet to pay feds another $30m in foreign bribery case Zimmer Biomet agreed to pay another $30 million to settle a foreign bribery case with the U.S. Justice Dept. and the Securities & Exchange Commission, after a 1st $22 million settlement nearly 5 years ago. The DoJ alleged that Biomet and its subsidiaries paid out more than $1.5 million in illegal kickbacks to employees of state-owned health services in Brazil and China. Biomet paid $22 million in March 2012 to settle the case with Justice and the SEC, agreeing to a deferred prosecution agreement to guard against further misconduct (Zimmer and Biomet closed their $14 billion merger in June 2015). Read more 4. Grifols pays $51m for minority stake in Access Biologicals Grifols said today that it paid $51 million for a 49% stake in Access Biologicals, in a deal that includes an option to acquire the rest of the business. That option, for the remaining 51% share in Vista, Calif.-based Access, goes live in 2022, Grifols said. The agreement also includes a provision to supply Access with non-human-use biologicals,...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 5 Source Type: news